HGEN News and Press, Humanigen Inc. From 07/13/22

The shares of Humanigen ( NASDAQ: HGEN ) fell ~80% to reach a 52-week low on Wednesday after the clinical-stage biotech announced that its experimental therapy Lenzilumab failed in a trial involving hospitalized COVID-19 patients. Removing the COVID sales for Lenzi...

Gainers: XORTX Therapeutics ( XRTX ) +39% . Gossamer Bio ( GOSS ) +24% . Rhythm Pharmaceuticals ( RYTM ) +23% . Apollo Endosurgery ( APEN ) +18% . Tyra Biosciences ( TYRA ) +15% . Losers: Humanigen ( HGEN ) -80% . Atara Biotherap...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Robert Way / Shutterstock.com Polestar Automotive (NASDAQ: PSNY ) stock is rising higher on Wednesday following an update on the company’s performance in 2022 . According to a company press rel...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/PhotobyTawat Humanigen (NASDAQ: HGEN ) stock is falling hard on Wednesday following the release of preliminary results from a clinical trial to treat patients suffering from Covid-19. ...

Humanigen HGEN -68% as trial for COVID-19 therapy fails . Atara Biotherapeutics ATRA -46% on interim analysis of phase 2 study for multiple sclerosis candidate. TherapeuticsMD TXMD -41% as merger agreement ends . Helius Medical Technologies ( HSDT...

The shares of clinical-stage biotech Humanigen, Inc. ( NASDAQ: HGEN ) dropped ~57% in the pre-market Wednesday after the company announced that its experimental antibody Lenzilumab failed in a trial involving hospitalized COVID-19 patients. ACTIV-5/BET-B trial was a pa...

Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”) has been informed of preliminary topline results from the National Institute of Allergy and Infectious Diseases’ (NIAID) ACTIV-5/BET-B trial evaluating lenzilumab plus remdesivir versus placebo plus remdesivir in hospital...

Gainers: Seritage Growth Properties ( SRG ) +72% . Aditxt ( ADTX ) +70% . Humanigen ( HGEN ) +35% . Clovis Oncology ( CLVS ) +30% . MyMD Pharmaceuticals ( MYMD ) +27% . Oramed Pharmaceuticals ( ORMP ) +26% . Kura ...

The National Institutes of Health (NIH) aims to enroll nearly 40,000 people this year as part of one of the largest research efforts to understand long COVID, a condition affecting an estimated one in five COVID-19 survivors aged 18 – 64 in the U.S. The $1.15B government fund...

Clinical-stage biotech Humanigen ( NASDAQ: HGEN ) rose more than 10% on Wednesday after the company announced a peer-reviewed publication of data supporting its investigational COVID-19 therapy lenzilumab. The publication in the medical journal Thorax was based on the data...